Guggenheim Capital LLC Vertex Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 139,291 shares of VRTX stock, worth $56.9 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

139,291

Previous 159,687 12.77%

Holding current value

$56.9 Million

Previous $74.8 Million 13.45%

% of portfolio

0.46%

Previous 0.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $9.38 Million - $10.3 Million	-20,396 Reduced 12.77%	139,291 $64.8 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $2.36 Million - $2.92 Million	-6,014 Reduced 3.63%	159,687 $74.8 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $2.43 Million - $2.66 Million	-5,961 Reduced 3.47%	165,701 $69.3 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $3.36 Million - $4.02 Million	9,784 Added 6.04%	171,662 $69.8 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $1.06 Million - $1.14 Million	3,146 Added 1.98%	161,878 $56.3 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $1.29 Million - $1.45 Million	-4,115 Reduced 2.53%	158,732 $55.9 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $1.73 Million - $1.97 Million	-6,112 Reduced 3.62%	162,847 $51.3 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.75 Million - $1.97 Million	-6,140 Reduced 3.51%	168,959 $48.8 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $5.49 Million - $6.12 Million	-20,047 Reduced 10.27%	175,099 $50.7 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $5.98 Million - $7.45 Million	-25,465 Reduced 11.54%	195,146 $55 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $1.98 Million - $2.33 Million	8,939 Added 4.22%	220,611 $57.6 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $810,174 - $1.02 Million	4,577 Added 2.21%	211,672 $46.5 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $1.66 Million - $1.86 Million	-9,157 Reduced 4.23%	207,095 $37.6 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $2.31 Million - $2.73 Million	12,343 Added 6.05%	216,252 $43.6 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $1.22 Million - $1.42 Million	-5,881 Reduced 2.8%	203,909 $43.8 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $3.66 Million - $4.89 Million	17,699 Added 9.21%	209,790 $49.6 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $787,146 - $933,244	-3,079 Reduced 1.58%	192,091 $52.3 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $820,747 - $1.08 Million	3,640 Added 1.9%	195,170 $56.7 Million
Q1 2020 Jun 02, 2020	SELL	$199.77 - $247.81 $4.39 Million - $5.44 Million	-21,965 Reduced 10.29%	191,530 $45.6 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $3.37 Million - $4.52 Million	-20,187 Reduced 8.64%	213,495 $46.7 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $447,823 - $504,020	-2,694 Reduced 1.14%	233,682 $39.6 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $1.7 Million - $1.97 Million	-10,327 Reduced 4.19%	236,376 $43.3 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $2 Million - $2.38 Million	12,245 Added 5.22%	246,703 $45.4 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $3.78 Million - $4.78 Million	-24,893 Reduced 9.6%	234,458 $38.9 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $561,224 - $644,908	-3,346 Reduced 1.27%	259,351 $50 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $68.9 Million - $80.4 Million	-473,152 Reduced 64.3%	262,697 $44.6 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $10.5 Million - $12.2 Million	-68,978 Reduced 8.57%	735,849 $120 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $51.6 Million - $58.5 Million	376,093 Added 87.72%	804,827 $121 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $63.5 Million - $69.6 Million	428,734	428,734 $65.2 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Vertex Pharmaceuticals Inc Transaction History